EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Associations between ABO non‐identical platelet transfusions and patient outcomes—A multicenter retrospective analysis

Daniel W Bougie iD, Sarah E Reese iD, Rebecca J Birch, Deborah B Bookwalter, Patrick K Mitchell, David Roh iD, Lisa Baumann Kreuziger, Ritchard G Cable, Ruchika Goel iD, Jerome Gottschall, Ronald George Hauser, Jeanne E Hendrickson iD und 9 weitere

Transfusion · 2023

DOI: 10.1111/trf.17319 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Transfusion, 2023. Verfasst von Daniel W Bougie und 20 weiteren Autor:innen. Beteiligte Einrichtung: Blood Research Institute, Versiti Milwaukee WI, Milwaukee, Wisconsin, USA. Hauptthemen laut MEDLINE: Platelet Transfusion, Transfusion Reaction. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Due to platelet availability limitations, platelet units ABO mismatched to recipients are often transfused. However, since platelets express ABO antigens and are collected in plasma which may contain ABO isohemagglutinins, it remains controversial as to whether ABO non‐identical platelet transfusions could potentially pose harm and/or have reduced efficacy. Study Design and Methods The large 4‐year publicly available Recipient Epidemiology and Donor Evaluation Study‐III (REDS‐III) database was used to investigate patient outcomes associated with ABO non‐identical platelet transfusions. Outcomes included mortality, sepsis, and subsequent platelet transfusion requirements.

Results

Following adjustment for possible confounding factors, no statistically significant association between ABO non‐identical platelet transfusion and increased risk of mortality was observed in the overall cohort of 21,176 recipients. However, when analyzed by diagnostic category and recipient ABO group, associations with increased mortality for major mismatched transfusions were noted in two of eight subpopulations. Hematology/Oncology blood group A and B recipients (but not group O) showed a Hazard Ratio (HR) of 1.29 (95%CI: 1.03–1.62) and intracerebral hemorrhage group O recipients (but not groups A and B) showed a HR of 1.75 (95%CI: 1.10–2.80). Major mismatched transfusions were associated with increased odds of receiving additional platelet transfusion each post‐transfusion day (through day 5) regardless of the recipient blood group.

Discussion

We suggest that prospective studies are needed to determine if specific patient populations would benefit from receiving ABO identical platelet units. Our findings indicate that ABO‐identical platelet products minimize patient exposure to additional platelet doses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet TransfusionTransfusion ReactionHumansBlood PlateletsRetrospective StudiesABO Blood-Group SystemBlood Group Incompatibility

Stichwörter der Autor:innen

ABOplatelet transfusion

Substanzen

ABO Blood-Group System

Autor:innen und Institutionen

  • Blood Research Institute, Versiti Milwaukee WI, Milwaukee, Wisconsin, USA.
  • Public Health and Epidemiology Practice, Westat, Rockville, Maryland, USA.
  • Columbia University, New York, New York, USA.
  • American Red Cross Scientific Affairs, Farmington, Connecticut, USA.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Medical Sciences Institute, Versiti, Milwaukee, Wisconsin, USA.

ORCID-Profile: Daniel W Bougie, Sarah E Reese, David Roh, Ruchika Goel, Jeanne E Hendrickson, Eldad A Hod, Cassandra D Josephson, Nareg H Roubinian

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Bougie, D. W., Reese, S. E., Birch, R. J., Bookwalter, D. B., Mitchell, P. K., Roh, D., Kreuziger, L. B., Cable, R. G., Goel, R., Gottschall, J., Hauser, R. G., Hendrickson, J. E., Hod, E. A., Josephson, C. D., Kahn, S., Kleinman, S. H., Mast, A. E., Ness, P. M., Roubinian, N. H., …, & NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P) (2023). Associations between ABO non‐identical platelet transfusions and patient outcomes—A multicenter retrospective analysis. Transfusion. https://doi.org/10.1111/trf.17319

Vancouver

Bougie DW, Reese SE, Birch RJ, Bookwalter DB, Mitchell PK, Roh D, et al. Associations between ABO non‐identical platelet transfusions and patient outcomes—A multicenter retrospective analysis. Transfusion. 2023. doi:10.1111/trf.17319

BibTeX
@article{Bougie2023,
  author = {Bougie, Daniel W and Reese, Sarah E and Birch, Rebecca J and Bookwalter, Deborah B and Mitchell, Patrick K and Roh, David and Kreuziger, Lisa Baumann and Cable, Ritchard G and Goel, Ruchika and Gottschall, Jerome and Hauser, Ronald George and Hendrickson, Jeanne E and Hod, Eldad A and Josephson, Cassandra D and Kahn, Stacie and Kleinman, Steven H and Mast, Alan E and Ness, Paul M and Roubinian, Nareg H and Sloan, Steven and NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P), NHLBI Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P)},
  title = {Associations between ABO non‐identical platelet transfusions and patient outcomes—A multicenter retrospective analysis},
  journal = {Transfusion},
  year = {2023},
  doi = {10.1111/trf.17319}
}
Kostenlos starten →